Index of medicine substances

Interferon beta 1A  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB07)

Interferon beta 1B  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB08)

Iobitridol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB11)

Iodine  •  Various | X-ray contrast media, iodinated | Non-watersoluble x-ray contrast media (V08AD01)

Iodixanol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB09)

Iodoform + butamben + eugenol  •  Alimentary tract and metabolism | Stomatological preparations | Stomatological preparations | Other agents for local oral treatment (A01AD11)

Ioflupan iodine 123  •  Various | Central nervous system | Iodine (123i) compounds (V09AB03)

Iohexol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB02)

Iomeprol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB10)

Iopamidol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB04)

Iopromide  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB05)

Ioversol  •  Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media (V08AB07)

Ipidacrin  •  Nervous system | Parasympathomimetics | Anticholinesterases (N07AA)

Ipilimumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX04)

Ipratropium bromide  •  Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics (R03BB01)

Ipratropium bromide + salbutamol  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL02)

Iptacopan  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors (L04AJ08)

Irbesartan  •  Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain (C09CA04)

Irbesartan + amlodipine  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB05)

Irbesartan + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA04)

Irinotecan  •  Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Topoisomerase 1 (TOP1) inhibitors (L01CE02)

Iron (III) hydroxide complex sucrose  •  Blood and blood forming organs | Iron preparations | Iron, parenteral preparations (B03AC02)

Iron (III) hydroxide polymaltosate + folic acid  •  Blood and blood forming organs | Iron preparations | Iron in combination with folic acid (B03AD04)

Iron (III) isomaltose complex  •  Blood and blood forming organs | Iron preparations | Iron, parenteral preparations (B03AC06)

Iron (III) maltol complex  •  Blood and blood forming organs | Iron preparations | Iron trivalent, oral preparations (B03AB10)

Iron carboxymaltose  •  Blood and blood forming organs | Iron preparations | Iron, parenteral preparations (B03AC01)

Iron gluconate  •  Blood and blood forming organs | Iron preparations | Iron bivalent, oral preparations (B03AA03)

Iron succinylated protein  •  Blood and blood forming organs | Iron preparations | Iron trivalent, oral preparations (B03AB09)

Iron sulfate  •  Blood and blood forming organs | Iron preparations | Iron bivalent, oral preparations (B03AA07)

Iron sulfate - glycine  •  Blood and blood forming organs | Iron preparations | Iron bivalent, oral preparations (B03AA01)